Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$101.38 n/a | n/a%
04/17/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 24.89B 11.20B 9.70B 8.39B
Cost of Sales 2.74B 2.51B 2.19B 1.82B
Gross Operating Profit 22.15B 8.69B 7.51B 6.56B
Selling, General, and Administrative Expenses 2.98B 1.70B 1.46B 1.24B
Research & Development 2.85B 2.12B 1.76B 1.23B
Operating Income before D & A (EBITDA) 16.32B 4.87B 4.29B 4.09B
Depreciation & Amortization 1.05B 344.70M 278.21M 302.23M
Interest Income 0.00 0.00 0.00 66.58M
Other Income - Net 3.00M -8.89M -37.28M 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 15.27B 4.52B 3.97B 3.86B
Interest Expense 412.00M 306.89M 360.92M 205.42M
Pre-Tax Income 14.86B 4.21B 3.61B 3.65B
Income Taxes 2.80B 1.15B 1.04B 861.94M
Minority Interest -42.00M -17.52M -17.97M -14.58M
Net Income From Continuing Operations 12.06B 3.06B 2.57B 2.79B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 12.06B 3.06B 2.57B 2.79B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 12.10B 3.07B 2.59B 2.80B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
12.06B 3.06B 2.57B 2.79B
Preferred Dividends
Net Income Available To Common 12.06B 3.06B 2.57B 2.79B
Basic EPS from Continuing Ops. 7.95 2.01 1.71 1.81
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 7.95 2.01 1.71 1.81
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 7.95 2.01 1.71 1.81
Basic Normalized Net Income/Share 7.95 2.01 1.71 1.81
EPS fr Continuing Ops. 7.35 1.81 1.64 1.77
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 7.35 1.81 1.64 1.77
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 7.35 1.81 1.64 1.78
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
7.35 1.81 1.64 1.77
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter